![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Issue contents]](/e/graphics/issuecontentsborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](im2061contents.gif)
Acta Cryst. (2008). E64, o1063 [ doi:10.1107/S1600536808013408 ]
Abstract: The title compound, C13H18N2O3, is an intermediate in the synthesis of compounds with medicinial applications. The crystal structure is stabilized by intermolecular N-H
O, C-HN and C-HO hydrogen bonds.
Online 14 May 2008
Copyright © International Union of Crystallography
IUCr Webmaster